Johnson & Johnson (JNJ) Tops Q1 EPS by 5c

Johnson & Johnson (NYSE: JNJ) reported Q1 EPS of $2.06, $0.05 better than the analyst estimate of $2.01. Revenue for the quarter came in at $20 billion versus the consensus estimate of $19.43 billion.

GUIDANCE:

Johnson & Johnson sees FY2018 EPS of $8.00-$8.20, versus the consensus of $8.10. Johnson & Johnson sees FY2018 revenue of $81-81.8 billion, versus the consensus of $81.13 billion.

For earnings history and earnings-related data on Johnson & Johnson (JNJ) click here.

You May Also Be Interested In

• Concentrix Corporation (CNXC) Misses Q2 EPS by 1c; Guides lower than expectations
• AeroVironment (AVAV) PT Lowered to $280 at Canaccord
• Novocure's Optune Pax wins CE Mark for pancreatic cancer